Catalyst Biosciences Inc

NASDAQ:CBIO  
1.08
-0.05 (-4.42%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)32.72M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.17 Million
Adjusted EPS-$0.59
See more estimates
10-Day MA$1.31
50-Day MA$2.97
200-Day MA$4.29
See more pivots

Catalyst Biosciences Inc Stock, NASDAQ:CBIO

611 Gateway Boulevard, Suite 710, South San Francisco, California 94080
Phone: +1.650.871.0761
Number of Employees: 56

Description

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.